American Journal of Ophthalmology
Volume 149, Issue 5 , Page 867, May 2010

Randomized Study of Bevacizumab vs Ranibizumab for Age-Related Macular Degeneration: Inappropriate Conclusions

Prato, Italy

No abstract is available. To read the body of this article, please view the Full Text online.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0002-9394(10)00015-2

doi:10.1016/j.ajo.2009.12.039

Refers to article:

  • Bevacizumab vs Ranibizumab for Age-Related Macular Degeneration: Early Results of a Prospective Double-Masked, Randomized Clinical Trial , 05 October 2009

    Manju L. Subramanian, Steven Ness, Gelareh Abedi, Ednan Ahmed, Mary Daly, Edward Feinberg, Sumit Bhatia, Payal Patel, Maileah Nguyen, Antoun Houranieh
    American Journal of Ophthalmology December 2009 (Vol. 148, Issue 6, Pages 875-882.e1)

American Journal of Ophthalmology
Volume 149, Issue 5 , Page 867, May 2010

Article Tools